Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
228.1 USD | -0.86% | -2.29% | -3.50% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.50% | 11.75B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+46.23% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
+20.18% | 11.72B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- JPMorgan Adjusts Price Target on Charles River Laboratories International to $280 From $270, Maintains Overweight Rating